Palazestrant
OP-1250-003
Phase 1 small_molecule active
Quick answer
Palazestrant for Metastatic Breast Cancer is a Phase 1 program (small_molecule) at Olema Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Olema Pharmaceuticals
- Indication
- Metastatic Breast Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active